Montelukast Sulphoxide
| Product Name | Montelukast Sulphoxide |
|---|---|
| Alternate Names | Montelukast Impurities, Impurities of Montelukast |
| CAT No. | CS-AB-00066 |
| CAS No. | 1152185-58-4 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 602.18 g/mol |
| Mol. For. | C₃₅H₃₆ClNO₄S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Montelukast |
| Canonical Smiles | CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S(=O)CC5(CC5)CC(=O)O)O |
| InchIKey | QFTNWCBEAVHLQA-XNHCCDLUSA-N |
| Inchl | InChI=1S/C35H36ClNO4S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(42(41)23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-,42?/m1/s1 |
| IUPAC | 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfinylmethyl]cyclopropyl]acetic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Montelukast Sulphoxide, also known as Montelukast S-oxide or MK-476, is a metabolite of Montelukast, a medication used to treat asthma and allergic rhinitis. Montelukast Sulphoxide is formed in the liver by the oxidation of Montelukast and has been found to have similar pharmacological properties as its parent drug.
The usage of Montelukast Sulphoxide has been studied for its potential therapeutic effects in the treatment of various inflammatory diseases, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD). Research has shown that Montelukast Sulphoxide has anti-inflammatory properties that can reduce airway inflammation and improve lung function in patients with asthma and COPD.
Chemically, Montelukast Sulphoxide is a chiral molecule, meaning that it exists in two mirror-image forms. The biological activity of each form can differ, which is why it is important to use the correct enantiomer for therapeutic purposes. Montelukast Sulphoxide is primarily eliminated from the body through the urine and feces, and its half-life ranges from 4 to 7 hours.
In conclusion, Montelukast Sulphoxide has shown potential as a therapeutic agent for the treatment of inflammatory diseases, particularly in the respiratory system. Further research is needed to fully understand its pharmacological properties and potential clinical applications.
Get an Instant Quote
Related Compounds
Des[3-[[(1-Carboxymethyl)cyclopropyl]methyl]thio]-2-propenyl Montelukast Mesylate | Montelukast Sulfone | Montelukast EP Impurity C (Mixture of isomers) | Montelukast cyclopropaneacetamide (Impurity) | Montelukast Chloroalcohol impurity | Dihydro Montelukast Sodium Salt | Montelukast Cyclizate Ether impurity | Montelukast EP impurity A | Montelukast Cyclopropaneacetonitrile | ent-Montelukast Sodium Salt | Montelukast Gem-dimethylmethylene Analogue | Montelukast (3R)-Hydroxy Propanol | Montelukast sodium racemate | Montelukast Methyl Ester | Montelukast EP impurity E | Montelukast methanesulfonate IMPURITY | Montelukast EP Impurity C (R isomer) | Dihydro Montelukast Sodium Salt | Montelukast EP Impurity B | Montelukast EP impurity F | Montelukast EP impurity H | Montelukast sulfone N-Oxide | Montelukast Acid impurity | Montelukast Bis-sulfide | Montelukast Dehydro Impurity | Montelukast Diol | Cyclopropane-1,1- diylbis(methylene) dimethanesulfonate | Montelukast EP Impurity D+E (Michael Adduct 1+2) | Montelukast EP impurity I | Montelukast Ketocarbinol Impurity | Montelukast Dicarboxylic Acid | Montelukast EP impurity D | Montelukast 3-Oxo Propanol Impurity | Montelukast EP impurity G |